Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
about
New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab eraPrimary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.Genetic background and evolution of relapses in aggressive B-cell lymphomas.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay.The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.Mutational profile of primary breast diffuse large B-cell lymphoma.Aggressive lymphoma 2016: revision of the WHO classification.Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides.TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis.Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.Management of aggressive lymphoma in very elderly patients.New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.Immunosenescence and lymphomagenesisAnalysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
P2860
Q26743352-2E36736A-7417-4AE9-A1ED-42D802AF2A6EQ33594139-3C4C652C-EC8C-4953-A23E-EE0B993A01BBQ33622342-57BBAA25-7C90-42B4-938E-8C8F72448CC8Q33701845-94AB9056-C670-43A6-B94A-710E40E6DB45Q33851726-C4D46DA1-7A1D-4993-8872-902D91004841Q37699251-73877EB7-1AC8-46C7-84D1-4D9ABE2886F6Q37718312-9E423CF7-E1F5-48B9-AC2C-2AD5C6176634Q37725413-C94AFAED-FAFF-44AB-B0C9-4395ED2289B8Q37725561-90B7CBB4-AAD0-4C5F-929B-7BDFC5FC7AB5Q38729502-D4F7966F-7CE7-4FB6-AB48-135126BD7282Q38754419-9CEE76F5-9CAD-4DBC-A843-25174E746285Q38764010-68313885-D7E0-4D2D-83BD-A1CBD71A4A9CQ38959472-286AD76B-C492-47B1-92C6-6F143B5177F7Q39336821-3BB12EE0-66DA-421B-A155-F370537035C7Q40238236-EF3D8F06-8D1E-442D-945A-622164B8A376Q41471491-8C0CDBC4-105A-4DC5-83E1-D40E5FFD7C6EQ42368339-E7C32D16-37FE-4360-8298-1929955B6BE1Q47102996-21E494E1-9CD0-472E-B988-5E0652787A98Q47118882-D1EA3950-555F-407E-B0AA-66B3691A43F2Q47123563-6F4D3E9D-8B2A-485F-A6EE-4B4FFA4D5FD8Q47873950-DE57246C-8CF6-4B73-882A-30AB76832D31Q48248047-668A6E8F-EE6D-42CC-940E-28E1F1B64662Q54108534-2694BAE0-1122-4907-9B2C-84289882B49CQ55177617-E4B0D011-7629-410F-B427-4096E3AD1B44Q55230268-A933C625-69CA-4E50-AAE0-8C1FD13B2E1AQ55299219-6CFBFE86-FCBC-4879-B43B-9C998B8EE7CDQ55508866-7835FCCD-2F42-4A38-848A-3EA1C84905EAQ58706440-31CDED81-1C84-4480-A0C4-077604D45694Q58737485-29673EB0-AA3A-4FC2-9DEA-4EF3BFBD72DF
P2860
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@en
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@nl
type
label
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@en
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@nl
prefLabel
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@en
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@nl
P2093
P50
P1476
Next-Generation Sequencing in ...... c Opportunities: a LYSA Study.
@en
P2093
André Bosly
Bertrand Coiffier
Bettina Fabiani
Catherine Maingonnat
Corinne Haioun
Danielle Canioni
Elodie Bohers
Fabienne Desmots
Fabrice Jardin
Frédéric Peyrade
P304
P356
10.1158/1078-0432.CCR-15-2305
P407
P50
P577
2016-01-27T00:00:00Z